Adagene Inc. , a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers.
Adagene stock last closed at $1.52, up 7.8% from the previous day, and has decreased 32.74% in one year. It has overperformed other stocks in the Biotechnology industry by 0.44 percentage points. Adagene stock is currently +14.72% from its 52-week low of $1.33, and -57.55% from its 52-week high of $3.58.
As of Apr 30, 2025, there are 58.89M shares of ADAG outstanding. The market value of ADAG is $71.61M. In the last 24 hours, 18,247 ADAG shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ADAG shares.
Based on our research, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you'll need to fill out some personal info so you are able to invest in ADAG today.
Now that you've finished signing up on the best stock app for beginners, you can securely and quickly fund your account:
Check out the video below if you need help transferring funds into your brokerage account.
Once you have selected the best place to buy Adagene stock, it's critical to analyze their stock before you buy, so you can understand the risk and upside.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on ADAG's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ADAG's intrinsic value.
Using relative valuations ratios:
You can do additional valuation analysis on ADAG's stock here.
Out of 1 Equities analysts who give forecasts on ADAG, the consensus analyst rating on ADAG is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Adagene stock forecast page.
Last year, ADAG revenue was $103.20k. Over the last five year, ADAG's revenue has grown by -26.47% per year. This was slower than the Biotechnology industry average of 45.66%.
Find out more about ADAG's earnings and revenue performance here.
In the last year, insiders at ADAG have not bought or sold any shares.
Get more info about who owns ADAG stock here.
No, Adagene doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two main options:
Press the Open button and eToro will place the order.
If you want more help with investing in stocks on eToro, watch the how to video below:
Now that you own some shares in ADAG, you'll want to stay up-to-date on your new investment.
Start a watchlist to keep tabs on your ADAG stock.
To summarize, here are the 6 steps to buy stock in Adagene:
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep track of your investment in Adagene, create a watchlist today.